Related Experiment Video
Updated: Aug 2, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology
N J Webb1, M M Fitzpatrick, D A Hughes
1Department of Paediatric Nephrology, Royal Manchester Children's Hospital, Pendlebury, Manchester M27 4HA, UK. nwebb@lycosmail.com
Insights
Varicella (chickenpox) vaccination in children with kidney failure shows high initial protection and sustained antibody levels. Vaccination before kidney transplant is recommended for better outcomes.
Area of Science:
- Pediatric Nephrology
- Immunology
- Vaccinology
Background:
- Children with renal failure are at increased risk of severe varicella (chickenpox).
- Assessing the efficacy of varicella vaccination in this vulnerable population is crucial.
Purpose of the Study:
- To determine the seroconversion rate and antibody persistence after varicella vaccination in children with renal failure.
- To evaluate the vaccine's effectiveness in preventing varicella infection.
Main Methods:
- 32 children with renal failure received two doses of varicella vaccine.
- Antibody titres were measured using enzyme-linked immunosorbent assay (ELISA).
- Follow-up included monitoring antibody levels and clinical outcomes, including varicella infections and renal transplantation.
Main Results:
- All children achieved initial seroconversion.
- At a mean follow-up of 20.3 months, 23 of 28 children maintained protective antibody titres.
- No child developed varicella despite known exposures; 2 children needed a booster dose.
- Among 11 children who underwent renal transplantation, 10 had protective titres at transplant, with 6 maintaining them at a mean of 23.4 months post-vaccination.
Conclusions:
- Varicella vaccination in children with renal failure leads to high seroconversion and sustained protective antibody titres.
- Vaccination prior to renal transplantation is advisable to enhance protection.
- The vaccine demonstrated a good safety profile with minor side effects.
Objectives:
To investigate the seroconversion rate and duration of persistence of protective antibody titres after varicella immunisation in children with renal failure.
Design:
32 children (25 end stage and 7 pre-end stage renal failure) were immunised using 2 x 2,000 plaque forming unit doses of varicella vaccine 3 months apart. Varicella antibody titres were measured by enzyme linked immunosorbent assay.
Results:
All children initially seroconverted after immunisation. At a mean follow up of 20.3 months, 23 of 28 had protective antibody titres, 4 children having died of unrelated causes. Two children required a third booster dose. 11 children underwent renal transplantation; 10 had protective titres at the time of transplantation and, at a mean of 23.4 months after immunisation, 6 currently have protective titres. Minor side effects occurred after 11 vaccine doses in 9 children. No child developed varicella, despite 10 clear episodes of exposure to the wild-type virus.
Conclusions:
Varicella immunisation in children with end stage and pre-end stage renal failure results in a high rate of seroconversion and persistence of protective antibody titres. More widespread use of the vaccine before renal transplantation is recommended.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
06:32A Neonatal Intravenous Transplant Model for Assessment of Early-Life Immune Activities Against Cancer Cells
Published on: June 26, 2026
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chickenpox
Respiratory Syncytial Virus Disease